This project focuses on biological activity of modified lignin that can be isolated from a by-product of paper and cellulose production. Modified lignin could apply to biomedicine as a food supplement with antioxidant effects, which could protect organism against negative environmental factors and diseases of affluence.
Effects of lignin will be characterized:
This project is based on our unique collaboration with commercial company VIDIA Inc. (Vestec), which focuses on a development of diagnostics in human medicine and environment. The results should help to introduce new nutritional supplements to protect humans against diseases of affluence, such as obesity, type 2 diabetes, and cardiovascular disease.
Supported by the Technology Agency of the Czech Republic (TA03010581; 2013-2015, PI: Ing. Michaela Poláková, VIDIA Inc.; co-PI: Martin Rossmeisl, MD, PhD, Institute of Physiology, CAS.